What VR Adviser, LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1615982 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 4.1M |
| ±0% |
| $394.8M |
| 12% |
ERASErasca, Inc. | 17.9M | +9.2% | $327.8M | 9.9% |
SYRESpyre Therapeutics, Inc. | 3M | −19.0% | $265M | 8% |
DNTHDianthus Therapeutics, Inc. | 1.2M | ±0% | $115M | 3.5% |
OCULOcular Therapeutix, Inc | 10.3M | ±0% | $101.6M | 3.1% |
DMRADamora Therapeutics, Inc. | 3.6M | ±0% | $93.7M | 2.8% |
SVRASavara Inc | 14.7M | +7.3% | $90.8M | 2.8% |
JBIOJade Biosciences, Inc. | 3.2M | ±0% | $71.6M | 2.2% |
COGTCogent Biosciences, Inc. | 1.6M | −17.9% | $63.6M | 1.9% |
VRDNViridian Therapeutics, Inc. | 3.3M | −16.1% | $59.8M | 1.8% |
VORVor Biopharma Inc. | 3M | ±0% | $56M | 1.7% |
DYNDyne Therapeutics, Inc. | 2.2M | ±0% | $48.3M | 1.5% |
MAZEMaze Therapeutics, Inc. | 1.6M | ±0% | $47.8M | 1.4% |
RLMDRelmada Therapeutics, Inc. | 6.8M | +41.3% | $47.4M | 1.4% |
ORICOric Pharmaceuticals, Inc. | 4.3M | ±0% | $46.8M | 1.4% |
CBIOCrescent Biopharma, Inc. | 2.1M | ±0% | $38.4M | 1.2% |
ZURAZura Bio Ltd | 6.4M | ±0% | $38M | 1.2% |
ANLAdlai Nortye Group Ltd. | 3.2M | ±0% | $36.9M | 1.1% |
ELVNEnliven Therapeutics, Inc. | 526.3K | −69.5% | $26.7M | 0.8% |
HELPHelus Pharma Inc. | 3.9M | ±0% | $25.5M | 0.8% |
CGEMCullinan Therapeutics, Inc. | 1.4M | ±0% | $25.1M | 0.8% |
IPSCCentury Therapeutics, Inc. | 8.7M | ±0% | $21.3M | 0.6% |
ARTVArtiva Biotherapeutics, Inc. | 2M | +27.0% | $19.8M | 0.6% |
CTMXCytomX Therapeutics, Inc. | 5M | −50.1% | $18.7M | 0.6% |
ACHVAchieve Life Sciences, Inc. | 2.8M | New | $18M | 0.5% |
PBLSParabilis Medicines, Inc. | 625K | New | $17.1M | 0.5% |
SRZNSurrozen, Inc. | 632.9K | ±0% | $16.4M | 0.5% |
KRROKorro Bio, Inc. | 1M | ±0% | $13.3M | 0.4% |
ANROAlto Neuroscience, Inc. | 500K | ±0% | $13.2M | 0.4% |
XFORX4 Pharmaceuticals, Inc | 1.9M | +485.2% | $9M | 0.3% |
RACCResearch Alliance Corp III | 300K | New | $3.2M | 0.1% |
INMInMed Pharmaceuticals Inc. | 32.7K | New | $50.7K | 0.1% |
